Found: 11
Select item for more details and to access through your institution.
Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 3, p. 357, doi. 10.1016/j.clgc.2023.02.007
- By:
- Publication type:
- Article
Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 2, p. 406, doi. 10.1177/1078155219859644
- By:
- Publication type:
- Article
Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 896, doi. 10.1177/1078155219832644
- By:
- Publication type:
- Article
Impact of an integrated oral chemotherapy program on patient adherence.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 5, p. 332, doi. 10.1177/1078155217703792
- By:
- Publication type:
- Article
Real-World Incidence and Severity of Hypertension Caused by Abiraterone Acetate in Patients With Metastatic Prostate Cancer.
- Published in:
- Annals of Pharmacotherapy, 2024, v. 58, n. 10, p. 994, doi. 10.1177/10600280231223213
- By:
- Publication type:
- Article
Safety of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients With Preexisting Renal Dysfunction.
- Published in:
- Annals of Pharmacotherapy, 2021, v. 55, n. 3, p. 303, doi. 10.1177/1060028020953501
- By:
- Publication type:
- Article
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0253021
- By:
- Publication type:
- Article
Denosumab for First-Line Treatment of Hypercalcemia Associated with Malignancy: Retrospective Analysis.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2021, v. 11, n. 3, p. 121
- By:
- Publication type:
- Article
Rates of Renal Toxicity in Cancer Patients Receiving Cisplatin With and Without Mannitol.
- Published in:
- 2014
- By:
- Publication type:
- journal article
The Role of Mannitol as a Nephroprotectant in Patients Receiving Cisplatin Therapy.
- Published in:
- Annals of Pharmacotherapy, 2012, v. 46, n. 2, p. 276, doi. 10.1345/aph.1Q333
- By:
- Publication type:
- Article